Oxford Gene Technology

Kidlington, United Kingdom Founded: 1995 • Age: 31 yrs Acquired By Sysmex
Genetics research and biomarker solutions are provided to research institutions.
Request Access

About Oxford Gene Technology

Oxford Gene Technology is a company based in Kidlington (United Kingdom) founded in 1995 was acquired by Sysmex in May 2017.. Oxford Gene Technology offers products and services including CytoCell FISH, SureSeq NGS, and CytoSure Arrays. Oxford Gene Technology operates in a competitive market with competitors including Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others.

  • Headquarter Kidlington, United Kingdom
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Oxford Gene Technology Ip Limited
  • Date of Incorporation 21 Sep, 1999
  • Jurisdiction KIDLINGTON, OXFORDSHIRE, UNITED KINGDOM
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $1.81 M (USD), Grant

    Mar 11, 2015

  • Investors
    Sysmex

    & 2 more

  • Employee Count
    Employee Count
  • Acquired by
    Sysmex

    (May 31, 2017)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Oxford Gene Technology

Oxford Gene Technology offers a comprehensive portfolio of products and services, including CytoCell FISH, SureSeq NGS, and CytoSure Arrays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Probes for detecting genetic aberrations in cancer research.

Panels for genetic profiling in haematological and solid tumours.

Arrays for cytogenetic and rare disease analysis.

People of Oxford Gene Technology
Headcount 50-200
Employee Profiles 30
Employee Profiles
People
Katherine Melville
Account Manager
People
James Reid
Head Of Data Analysis
People
Adrian Smith
CEO
People
Harry Petch-Smith
Computational Biologist

Unlock access to complete

Funding Insights of Oxford Gene Technology

  • Total Funding
  • Total Rounds 2
  • Last Round Grant — $1.8M
  • First Round
  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2015 Amount Grant - Oxford Gene Technology Valuation

investors

Dec, 2011 Amount Grant - Oxford Gene Technology Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Oxford Gene Technology

Oxford Gene Technology has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Sysmex, European Union and SBRI Healthcare. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Delivers business and technological solutions to identify and address healthcare challenges.
Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Developer of diagnostic instruments, reagents, and related software
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Oxford Gene Technology

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Oxford Gene Technology

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Oxford Gene Technology Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Oxford Gene Technology

Oxford Gene Technology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, GenScript, Sino Biological and Miltenyi Biotec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
domain founded_year HQ Location
Reagents and instruments are provided for life sciences research.
domain founded_year HQ Location
Reagents and kits are provided for clinical research applications.
domain founded_year HQ Location
Develops tools and products for research and clinical application
domain founded_year HQ Location
Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Oxford Gene Technology

Frequently Asked Questions about Oxford Gene Technology

When was Oxford Gene Technology founded?

Oxford Gene Technology was founded in 1995 and raised its 1st funding round 16 years after it was founded.

Where is Oxford Gene Technology located?

Oxford Gene Technology is headquartered in Kidlington, United Kingdom. It is registered at Kidlington, Oxfordshire, United Kingdom.

What does Oxford Gene Technology do?

Oxford Gene Technology was founded in 1995 and is headquartered in Kidlington, United Kingdom. Operations focus on the genetics sector, where NGS products, array products, and FISH probes are developed and supplied to clinical and academic institutions. Brands such as CytoSure for microarrays, Cytocell for FISH probes, and SureSeq for next-generation sequencing are utilized to support the identification of genetic variations associated with diseases.

Who are the top competitors of Oxford Gene Technology?

Oxford Gene Technology's top competitors include Abcam, Sino Biological and Meridian Bioscience.

What products or services does Oxford Gene Technology offer?

Oxford Gene Technology offers CytoCell FISH, SureSeq NGS, and CytoSure Arrays.

Who are Oxford Gene Technology's investors?

Oxford Gene Technology has 3 investors. Key investors include Sysmex, European Union, and SBRI Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available